View Post

Breast cancer breakthrough: Sarah Cannon discusses newly FDA-approved immunotherapy

Spring brings new hope and new beginnings, and for breakthroughs in cancer treatment, this season is off to a promising start. Earlier this month, the U.S. Food and Drug Administration (FDA) approved the first-ever immunotherapy (atezolizumab), in combination with chemotherapy, for the treatment of breast cancer. “Immunotherapy is a drug that we’ve been using in…
View Post